An analysis of substitution, deletion and insertion mutations in cancer genes

Nucleic Acids Research

Volumn 40, Issue 14, 2012, Pages 6401-6413

  Iengar, Prathima ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ABL1 GENE; ALK GENE; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; APC GENE; ARTICLE; ATM GENE; BRAF GENE; BRCA2 GENE; CARBOXY TERMINAL SEQUENCE; CDC73 GENE; CDH1 GENE; CDKN2A GENE; CEBPA GENE; CSF1R GENE; CTNNB1 GENE; DNA METHYLATION; EGFR GENE; ERBB2 GENE; FBXW7 GENE; FGFR3 GENE; FLT3 GENE; FRAMESHIFT MUTATION; GATA1 GENE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENE MUTATION; GENETIC ANALYSIS; GENETIC DATABASE; GENETIC VARIABILITY; GNAS GENE; HNF1A GENE; HRAS GENE; JAK2 GENE; KIT GENE; KRAS GENE; MEN1 GENE; MET GENE; MLH1 GENE; MPL GENE; MSH2 GENE; MSH6 GENE; NF1 GENE; NF2 GENE; NOTCH1 GENE; NPM1 GENE; NRAS GENE; ONCOGENE; PDGFRA GENE; PIK3CA GENE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PTCH1 GENE; PTEN GENE; PTPN11 GENE; RB1 GENE; RET GENE; RUNX1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SMAD4 GENE; SMARCA4 GENE; SMARCB1 GENE; SMO GENE; SOCS1 GENE; STK11 GENE; STOP CODON; TP53 GENE; TSHR GENE; TUMOR SUPPRESSOR GENE; VHL GENE; WT1 GENE;

AMINO ACID SUBSTITUTION; GENES, NEOPLASM; GENES, TUMOR SUPPRESSOR; HUMANS; INDEL MUTATION; MUTAGENESIS, INSERTIONAL; MUTATION; NEOPLASMS; PROTO-ONCOGENES; SEQUENCE DELETION;

EID: 84864957276     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gks290     Document Type: Article

References (48)

1. Stehelin, D., Varmus, H.E., Bishop, J.M. and Vogt, P.K. (1976) DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature, 260, 170-173.
2. Tabin, C.J., Bradley, S.M., Bargmann, C.I., Weinberg, R.A., Papageorge, A.G., Scolnick, E.M., Dhar, R., Lowy, D.R. and Chang, E.H. (1982) Mechanism of activation of a human oncogene. Nature, 300, 143-9. (Pubitemid 12006346)
3. Harris, H., Miller, O.J., Klein, G., Worst, P. and Tachibana, T. (1969) Suppression of malignancy by cell fusion. Nature, 223, 363-368.
4. Knudson, A.G. (1971) Mutation and cancer: statistical study of retinoblastoma. Proc. Natl Acad. Sci. USA, 68, 820-823.
5. Weinberg, R.A. (1991) Tumor suppressor genes. Science, 254, 1138-46. (Pubitemid 21917438)
6. Vogelstein, B. and Kinzler, K.W. (2004) Cancer genes and the pathways they control. Nat. Med., 10, 789-799. (Pubitemid 39070849)
7. Sjö blom, T., Jones, S., Wood, L.D., Parsons, D.W., Lin, J., Barber, T.D., Mandelker, D., Leary, R.J., Ptak, J., Silliman, N. et al. (2006) The consensus coding sequences of human breast and colorectal cancers. Science, 314, 268-274. (Pubitemid 44571966)
8. Hayden, E.C. (2008) Cancer complexity slows quest for cure. Nature, 455, 148.
9. Futreal, P.A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N. and Stratton, M.R. (2004) A census of human cancer genes. Nat. Rev. Cancer, 4, 177-183. (Pubitemid 38337497)
10. Forbes, S., Clements, J., Dawson, E., Bamford, S., Webb, T., Dogan, A., Flanagan, A., Teague, J., Wooster, R., Futreal, P.A. et al. (2006) COSMIC 2005. Br. J. Cancer, 94, 318-322. (Pubitemid 43151554)
11. Forbes, S.A., Bhamra, G., Bamford, S., Dawson, E., Kok, C., Clements, J., Menzies, A., Teague, J.W., Futreal, P.A. and Stratton, M.R. (2008) The Catalogue of Somatic Mutations in Cancer (COSMIC). Curr. Protoc. Hum. Genet., Chapter 10, Unit 10
12. Forbes, S.A., Tang, G., Bindal, N., Bamford, S., Dawson, E., Cole, C., Kok, C.Y., Jia, M., Ewing, R., Menzies, A. et al. (2010) COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer. Nucleic Acids Res., 38, D652-D657.
13. Greenman, C., Stephens, P., Smith, R., Dalgliesh, G.L., Hunter, C., Bignell, G., Davies, H., Teague, J., Butler, A. and Stevens, C. (2007) Patterns of somatic mutation in human cancer genomes. Nature, 446, 153-158. (Pubitemid 46398669)
14. Stratton, M.R., Campbell, P.J. and Futreal, P.A. (2009) The cancer genome. Nature, 458, 719-724.
15. Pleasance, E.D., Cheetham, R.K., Stephens, P.J., McBride, D.J., Humphray, S.J., Greenman, C.D., Varela, I., Lin, M.-L., Ordó ñ ez, G.R., Bignell, G.R. et al. (2010) A comprehensive catalogue of somatic mutations from a human cancer genome. Nature, 463, 191-196.
16. Kaminker, J.S., Zhang, Y., Waugh, A., Haverty, P.M., Peters, B., Sebisanovic, D., Stinson, J., Forrest, W.F., Bazan, J.F., Seshagiri, S. et al. (2007) Distinguishing Cancer-Associated Missense Mutations from Common Polymorphisms. Cancer Res., 67, 465-473. (Pubitemid 46192182)
17. Kaminker, J.S., Zhang, Y., Watanabe, C. and Zhang, Z. (2007) CanPredict: a computational tool for predicting cancer-associated missense mutations. Nucleic Acids Res., 35, W595-W598.
18. Carter, H., Chen, S., Isik, L., Tyekucheva, S., Velculescu, V.E., Kinzler, K.W., Vogelstein, B. and Karchin, R. (2009) Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. Cancer Res., 69, 6660-6667.
19. Torkamani, A. and Schork, N.J. (2008) Prediction of cancer driver mutations in protein kinases. Cancer Res., 68, 1675-1682. (Pubitemid 351416551)
20. Reva, B., Antipin, Y. and Sander, C. (2011) Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res., 39, e118.
21. Stone, E.A. and Sidow, A. (2005) Physicochemical constraint violation by missense substitutions mediates impairment of protein function and disease severity. Genome Res., 15, 978-986. (Pubitemid 40994218)
22. Thomas, P.D. and Kejariwal, A. (2004) Coding single-nucleotide polymorphisms associated with complex vs. Mendelian disease: evolutionary evidence for differences in molecular effects. Proc. Natl Acad. Sci. USA, 101, 15398-15403. (Pubitemid 39441553)
23. Shi, Z. and Moult, J. (2011) Structural and functional impact of cancer-related missense somatic mutations. J. Mol. Biol., 413, 495-512.
24. Yeang, C.H., McCormick, F. and Levine, A. (2008) Combinatorial patterns of somatic gene mutations in cancer. FASEB J., 22, 2605-2622.
25. Cui, Q. (2010) A network of cancer genes with co-occurring and anti-co-occurring mutations. PLoS ONE, 5, e13180.
26. Spiegel, M.R., Schiller, J. and Srinivasan, R.A. (2000) Schaum's Outlines Probability and Statistics, chapter 6, 2nd edn. McGraw-Hill, New York, p. 218, problem 6.27.
27. Carlini, D.B. and Stephan, W. (2003) In vivo introduction of unpreferred synonymous codons into the Drosophila Adh gene results in reduced levels of ADH protein. Genetics, 163, 239-243. (Pubitemid 36222668)
28. Bird, A.P. (1980) DNA methylation and the frequency of CpG in animal DNA. Nucleic Acids Res., 8, 1499-1504.
29. Arnheim, N. and Calabrese, P. (2009) Understanding what determines the frequency and pattern of human germline mutations. Nat. Rev. Genet., 10, 478-488.
30. Cooper, D.N. and Youssoufian, H. (1988) The CpG dinucleotide and human genetic disease. Human Genet., 78, 151-155. (Pubitemid 18069872)
31. Subramanian, S. and Kumar, S. (2003) Neutral substitutions occur at a faster rate in exons than in noncoding DNA in primate genomes. Genome Res., 13, 838-844. (Pubitemid 36621744)
32. Yoon, J.-H., Smith, L.E., Feng, Z., Tang, M., Lee, C.-S. and Pfeifer, G.P. (2001) Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers. Cancer Res., 61, 7110-7117. (Pubitemid 32946502)
33. Hodgkinson, A. and Eyre-Walker, A. (2011) Variation in the mutation rate across mammalian genomes. Nat. Rev. Genet., 12, 756-766.
34. Thomas, N.E., Alexander, A., Edmiston, S.N., Parrish, E., Millikan, R.C., Berwick, M., Groben, P., Ollila, D.W., Mattingly, D. and Conway, K. (2004) Tandem BRAF mutations in primary invasive melanomas. J. Invest. Dermatol., 122, 1245-1250. (Pubitemid 38651100)
35. Skinner, A.M., Dan, C. and Turker, M.S. (2008) The frequency of CC to TT tandem mutations in mismatch repair-deficient cells is increased in a cytosine run. Mutagenesis, 23, 87-91.
36. Schneider, A., Cannarozzi, G.M. and Gonnet, G.H. (2005) Empirical codon substitution matrix. BMC Bioinformatics, 6, 134.
37. Davies, H., Bignell, G.R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M.J., Bottomley, W. et al. (2002) Mutations of the BRAF gene in human cancer. Nature, 417, 949-954. (Pubitemid 34716871)
38. Dixit, A., Yi, L., Gowthaman, R., Torkamani, A., Schork, N.J. and Verkhiver, G.M. (2009) Sequence and structure signatures of cancer mutation hotspots in protein kinases. PLoS ONE, 4, e7485.
39. Mills, R.E., Pittard, W.S., Mullaney, J.M., Farooq, U., Creasy, T.H., Mahurkar, A.A., Kemeza, D.M., Strassler, D.S., Ponting, C.P., Webber, C. et al. (2011) Natural genetic variation caused by small insertions and deletions in the human genome. Genome Res., 21, 830-839.
40. Boeckmann, B., Bairoch, A., Apweiler, R., Blatter, M.C., Estreicher, A., Gasteiger, E., Martin, M.J., Michoud, K., O'Donovan, C., Phan, I. et al. (2003) The Swiss-Prot protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res., 31, 365-370. (Pubitemid 36157284)
41. Grisendi, S., Mecucci, C., Falini, B. and Pandolfi, P.P. (2006) Nucleophosmin and cancer. Nat. Rev. Cancer, 6, 493-505. (Pubitemid 43980539)
42. Li, J., Sejas, D.P., Burma, S., Chen, D.J. and Pang, Q. (2007) Nucleophosmin suppresses oncogene-induced apoptosis and senescence and enhances oncogenic cooperation in cells with genomic instability. Carcinogenesis, 28, 1163-1170. (Pubitemid 47062674)
43. Hanlon, L., Avila, J.L., Demarest, R.M., Troutman, S., Allen, M., Ratti, F., Rustgi, A.K., Stanger, B.Z., Radtke, F., Adsay, V. et al. (2010) Notch1 functions as a tumor suppressor in a model of K-ras-induced pancreatic ductal adenocarcinoma. Cancer Res., 70, 4280-4286.
44. Chapiro, E., Russell, L., Radford-Weiss, I., Bastard, C., Lessard, M., Struski, S., Cave, H., Fert-Ferrer, S., Barin, C., Maarek, O. et al. (2006) Overexpression of CEBPA resulting from the translocation t(14;19)(q32;q13) of human precursor B acute lymphoblastic leukemia. Blood, 108, 3560-3563.
45. Rogozin, I.B. and Pavlov, Y.I. (2003) Theoretical analysis of mutation hotspots and their DNA sequence context specificity. Mutat. Res., 544, 65-85. (Pubitemid 36897770)
46. Parsons, D.W., Jones, S., Zhang, X., Lin, J.C.H., Leary, R.J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.M., Gallia, G.L. et al. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science, 321, 1807-12.
47. Yan, H., Parsons, D.W., Jin, G., McLendon, R., Rasheed, B.A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G.J. et al. (2009) IDH1 and IDH2 mutations in gliomas. New Engl. J. Med., 360, 765-773.
48. den Dunnen, J.T. and Antonarakis, S.E. (2000) Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum. Mutat., 15, 7-12. (Pubitemid 30036162)